Zhou, Ming

Ultra-processed food consumption and the risk of non-alcoholic fatty liver disease in the tianjin chronic low-grade systemic inflammation and health cohort study

Zhang, S., Gan, S., Zhang, Q., Liu, L., Meng, G., Yao, Z., Wu, H., Gu, Y., Wang, Y., Zhang, T., et al. (2022) · International Journal of Epidemiology

Consumer Attitudes and Food LabelingLiver Disease Diagnosis and Treatment

Cited by 113

Soft drink consumption and risk of nonalcoholic fatty liver disease: results from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) cohort study

Zhang, S., Gu, Y., Bian, S., Lu, Z., Zhang, Q., Liu, L., Meng, G., Yao, Z., Wu, H., Wang, Y., et al. (2021) · The American Journal of Clinical Nutrition

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and Disease

Cited by 70

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study

Simó, R., Guerci, B., Schernthaner, G., Gallwitz, B., Rosas-Guzmàn, J., Dotta, F., Festa, A., Zhou, M., & Kiljański, J. (2015) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 47